Physician

Jo P Deal, MD

According to 2025 Medicare claims, Jo Deal, MD (NPI: 1003826272) practices infectious disease in the Jackson, MS market, with the plurality of this provider's patient population coming from Rankin, MS. This provider's primary affiliated billing organization is REVITALIZE HYDRATION THERAPY, LLC (NPI: 1285261123; TIN: 834446177) and primary practice location at 39232-9006. Deal is affiliated with the Health Leaders Network of Mississippi LLC (ACO ID: A5148), participating under the MSSP model.

Deal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 335 traditional Medicare patients, billed 138,532 HCPCS/CPT codes, and received $1,413,797 in Medicare payments. The top billing code was 96401 (Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle). Part D data shows 717 prescription claims across 72 beneficiaries totaling $1,297,400 in drug costs, led by Arikayce (Amikacin Liposomal/Neb.Accessr). DME data shows 560 claims. Open Payments data shows 42 records totaling $742. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $141,920 to $1,413,797. In contrast, Part D prescription costs have fallen sharply in recent years, from $1,624,195 to $1,297,400. For DME billing, this smaller-volume category rose steadily, from $14,955 to $44,957.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	445	1,905	$141,920
2016	366	1,537	$100,631
2017	433	1,925	$128,241
2018	400	1,737	$105,859
2019	356	1,544	$98,642
2020	346	1,188	$75,890
2021	270	983	$71,648
2022	174	1,027	$49,885
2023	207	96,881	$792,404
2024	335	138,532	$1,413,797

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	284	3,944	$1,624,195
2016	279	3,569	$2,122,471
2017	297	4,178	$2,549,831
2018	242	3,585	$2,566,420
2019	233	3,523	$3,162,315
2020	210	3,187	$3,994,445
2021	190	2,593	$3,173,069
2022	161	1,874	$2,252,853
2023	91	801	$1,178,871
2024	72	717	$1,297,400

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	38	482	$676,273
2016	42	563	$695,257
2017	29	626	$620,921
2018	49	753	$756,420
2019	94	1,155	$1,185,675
2020	114	1,235	$1,551,737
2021	104	1,238	$1,775,066
2022	77	1,007	$1,530,658
2023	34	606	$971,921
2024	29	560	$887,372

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	77	238	$48
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	140	298	$40
J1437	Injection, ferric derisomaltose, 10 mg	91	9,600	$16
36415	Insertion of needle into vein for collection of blood sample	82	134	$9
J3490	Unclassified drugs	88	94	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Arikayce	Amikacin Liposomal/Neb.Accessr	14	392	$210,061
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	48	1,440	$201,126
Rukobia	Fostemsavir Tromethamine	21	630	$175,458
Juluca	Dolutegravir/Rilpivirine	40	1,200	$152,608
Dovato	Dolutegravir Sodium/Lamivudine	38	1,320	$134,526

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	98	$429,464
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	78	$415,137
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	35	$32,696
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	14	150	$8,122
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	15	171	$1,726

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$742	ViiV Healthcare Company
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jo P. Deal, MD?

Tedicare shows public-source Medicare data for Jo P. Deal, MD (NPI 1003826272), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jo P. Deal, MD have ACO affiliation data?

Jo P. Deal, MD is shown with ACO affiliation data for Health Leaders Network of Mississippi LLC (MSSP, ACO ID A5148).

What billing organization is linked to Jo P. Deal, MD?

Jo P. Deal, MD is linked to REVITALIZE HYDRATION THERAPY, LLC (billing NPI 1285261123) in the available physician profile data.

Does Jo P. Deal, MD have Open Payments data?

Jo P. Deal, MD has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.